HGHAF(HGHAF)
HGHAF
No analyst ratings available
No analyst price targets available for HGHAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $22M | $25M | $27M | $28M | $24M | $9M | $12M | $23M |
| Low | $22M | $25M | $27M | $28M | $24M | $9M | $12M | $23M |
| High | $22M | $25M | $27M | $28M | $24M | $9M | $12M | $23M |
| EBITDA Avg | $1M | $1M | $2M | $2M | $1M | $558,845 | $697,306 | $1M |
| Low | $1M | $1M | $2M | $2M | $1M | $558,845 | $697,306 | $1M |
| High | $1M | $1M | $2M | $2M | $1M | $558,845 | $697,306 | $1M |
| EBIT Avg | $-3M | $-4M | $-4M | $-4M | $-4M | $-1M | $-2M | $-3M |
| Low | $-3M | $-4M | $-4M | $-4M | $-4M | $-1M | $-2M | $-3M |
| High | $-3M | $-4M | $-4M | $-4M | $-4M | $-1M | $-2M | $-3M |
| Net Income Avg | $-6M | $-5M | $-3M | $-2M | $-3M | $-6M | $-2M | — |
| Low | $-6M | $-5M | $-3M | $-2M | $-3M | $-6M | $-2M | — |
| High | $-6M | $-5M | $-3M | $-2M | $-3M | $-6M | $-2M | — |
| EPS Avg | $-0.46 | $-0.37 | $-0.25 | $-0.17 | $-0.24 | $-0.49 | $-0.15 | — |
| Low | $-0.46 | $-0.37 | $-0.25 | $-0.17 | $-0.24 | $-0.49 | $-0.15 | — |
| High | $-0.46 | $-0.37 | $-0.25 | $-0.17 | $-0.24 | $-0.49 | $-0.15 | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / — |